Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.25
Bid: 5.00
Ask: 5.50
Change: 0.00 (0.00%)
Spread: 0.50 (10.00%)
Open: 5.25
High: 5.25
Low: 5.00
Prev. Close: 5.25
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK shareholder meetings calendar - next 7 days

Mon, 15th Nov 2021 16:05

Tuesday 16 November 
Craneware PLCAGM
Dunelm Group PLCAGM
James Halstead PLCAGM
New Star Investment Trust PLCAGM
Wednesday 17 November 
AMTE Power PLCAGM
Berkeley Energia LtdAGM
BMO Real Estate Investments LtdAGM
Caribbean Investment Holdings LtdGM re delisting from AIM
Celtic PLCAGM
Henderson Eurotrust PLCAGM
Ncondezi Energy LtdAGM
Pacific Horizon Investment Trust PLCAGM
Picton Property Income LtdAGM
Rainbow Rare Earths LtdAGM
Smiths Group PLCAGM
Smiths Group PLCGM re sale of Smiths Medical
Thursday 18 November 
Avast PLCGM re takeover by NortonLifeLock
Avingtrans PLCAGM
Close Brothers Group PLCAGM
Eagle Eye Solutions Group PLCAGM
Finsbury Food Group PLCAGM
FirstGroup PLCGM re tender offer
Fonix Mobile PLCAGM
FW Thorpe PLCAGM
IronRidge Resources LtdAGM re gold demerger, name change
James Halstead PLCAGM
JD Wetherspoon PLCAGM
Litigation Capital Management LtdAGM
Maestrano Group PLCAGM
Omni Egis PLCGM - re cancellation of AQSE listing
Panthera Resources PLCAGM
President Energy PLCGM re dividend in specie of shares in Atome Energy
Friday 19 November 
Blue Prism Group PLCGM re Bali Bidco takeover
Diurnal Group PLCAGM
eEnergy Group PLCAGM
KCR Residential REIT PLCAGM
Kier Group PLCAGM
Marble Point Loan Financing LtdAGM
Petra Diamonds LtdAGM
Starcom PLCGM re name change, share consolidation
Monday 22 November 
Allergy Therapeutics PLCAGM
Crystal Amber Fund LtdAGM
Mila Resources PLCGM re placing, subscription and buy of Kathleen Valley stake
Mountview Estates PLCGM re director re-appointments
Norish PLCEGM re name change, share subdivision and change in articles of association
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
18 Feb 2016 08:08

Allergy Therapeutics Completes Enrolment For Grass Pollen Drug Study

Read more
13 Jan 2016 09:38

Allergy Therapeutics Revenue Up In First Half, Full Year Seen In Line

Read more
7 Dec 2015 07:54

Allergy Therapeutics Begins US Phase II Study Of Grass Allergy Vaccine

Read more
30 Nov 2015 09:25

Allergy Therapeutics Completes Patient Enrolment For Birch Study

Read more
17 Nov 2015 14:36

Allergy Therapeutics raises £12m to develop peanut and dust mite treatments

(ShareCast News) - Shares in Allergy Therapeutics fell as, despite a strong trading update, the company launched a £12m discounted fundraising to speed development of treatments for peanut allergy and house dust mites allergies. The AIM-listed company completes the institutional placing by mid-after

Read more
17 Nov 2015 13:03

UPDATE: Allergy Therapeutics Raises GBP11.5 Million To Fund Growth (ALLISS)

Read more
17 Nov 2015 10:14

Allergy Therapeutics To Raise GBP12 Million To Fund Growth (ALLISS)

Read more
16 Nov 2015 16:37

AGM, EGM Calendar - Week Ahead

Read more
4 Nov 2015 10:43

Allergy Therapeutics To Present Adjuvant Data At Spain Conference

Read more
13 Oct 2015 08:43

BROKER RATINGS SUMMARY: Citi Cuts AB Foods As UBS Raises Smiths Group

Read more
21 Sep 2015 08:11

Allergy Therapeutics Says Outlook "Very Positive" As Profit Falls

Read more
14 Sep 2015 14:58

Earnings, Trading Statements Calendar - Week Ahead

Read more
1 Sep 2015 08:35

Allergy Therapeutics Enrols First Patient For Birch Drug Study

Read more
10 Aug 2015 07:23

Allergy Therapeutics Says Paper Published In World Allergy Journal

Read more
27 Jul 2015 16:58

Allergy Technologies' chief executive buys 50,000 shares

(ShareCast News) - The chief executive of Allergy Therapeutics bought new shares in the company few days after releasing a positive trading update. Manuel Llobet purchased 50,000 shares for an individual price of 24.45p, spending a total of £12,225. After the transaction, Llobet holds 3.175m shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.